HLTRF
Price
$3.80
Change
-$0.03 (-0.78%)
Updated
Sep 26 closing price
Capitalization
121.98M
INDV
Price
$23.92
Change
+$1.11 (+4.87%)
Updated
Sep 26 closing price
Capitalization
2.98B
25 days until earnings call
Interact to see
Advertisement

HLTRF vs INDV

Header iconHLTRF vs INDV Comparison
Open Charts HLTRF vs INDVBanner chart's image
HLS Therapeutics
Price$3.80
Change-$0.03 (-0.78%)
Volume$100
Capitalization121.98M
Indivior
Price$23.92
Change+$1.11 (+4.87%)
Volume$2.81M
Capitalization2.98B
HLTRF vs INDV Comparison Chart in %
Loading...
HLTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLTRF vs. INDV commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLTRF is a Hold and INDV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (HLTRF: $3.80 vs. INDV: $23.92)
Brand notoriety: HLTRF and INDV are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HLTRF: 19% vs. INDV: 85%
Market capitalization -- HLTRF: $121.59M vs. INDV: $2.98B
HLTRF [@Pharmaceuticals: Generic] is valued at $121.59M. INDV’s [@Pharmaceuticals: Generic] market capitalization is $2.98B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLTRF’s FA Score shows that 1 FA rating(s) are green whileINDV’s FA Score has 0 green FA rating(s).

  • HLTRF’s FA Score: 1 green, 4 red.
  • INDV’s FA Score: 0 green, 5 red.
According to our system of comparison, both HLTRF and INDV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLTRF’s TA Score shows that 3 TA indicator(s) are bullish while INDV’s TA Score has 5 bullish TA indicator(s).

  • HLTRF’s TA Score: 3 bullish, 3 bearish.
  • INDV’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, INDV is a better buy in the short-term than HLTRF.

Price Growth

HLTRF (@Pharmaceuticals: Generic) experienced а -0.78% price change this week, while INDV (@Pharmaceuticals: Generic) price change was +6.26% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

INDV is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INDV($2.98B) has a higher market cap than HLTRF($122M). INDV YTD gains are higher at: 92.438 vs. HLTRF (41.264). INDV has higher annual earnings (EBITDA): 261M vs. HLTRF (15.5M). INDV has more cash in the bank: 510M vs. HLTRF (12.2M). HLTRF has less debt than INDV: HLTRF (55.6M) vs INDV (366M). INDV has higher revenues than HLTRF: INDV (1.17B) vs HLTRF (56.4M).
HLTRFINDVHLTRF / INDV
Capitalization122M2.98B4%
EBITDA15.5M261M6%
Gain YTD41.26492.43845%
P/E RatioN/A29.53-
Revenue56.4M1.17B5%
Total Cash12.2M510M2%
Total Debt55.6M366M15%
FUNDAMENTALS RATINGS
HLTRF vs INDV: Fundamental Ratings
HLTRF
INDV
OUTLOOK RATING
1..100
3355
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
94
Overvalued
PROFIT vs RISK RATING
1..100
10049
SMR RATING
1..100
9677
PRICE GROWTH RATING
1..100
4737
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
785

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HLTRF's Valuation (25) in the null industry is significantly better than the same rating for INDV (94). This means that HLTRF’s stock grew significantly faster than INDV’s over the last 12 months.

INDV's Profit vs Risk Rating (49) in the null industry is somewhat better than the same rating for HLTRF (100). This means that INDV’s stock grew somewhat faster than HLTRF’s over the last 12 months.

INDV's SMR Rating (77) in the null industry is in the same range as HLTRF (96). This means that INDV’s stock grew similarly to HLTRF’s over the last 12 months.

INDV's Price Growth Rating (37) in the null industry is in the same range as HLTRF (47). This means that INDV’s stock grew similarly to HLTRF’s over the last 12 months.

INDV's P/E Growth Rating (100) in the null industry is in the same range as HLTRF (100). This means that INDV’s stock grew similarly to HLTRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HLTRFINDV
RSI
ODDS (%)
Bearish Trend 3 days ago
45%
Bearish Trend 3 days ago
60%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
45%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
38%
Bullish Trend 3 days ago
75%
MACD
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 4 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
54%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
46%
Bearish Trend 3 days ago
70%
Advances
ODDS (%)
N/A
Bullish Trend 24 days ago
73%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
54%
Bullish Trend 3 days ago
67%
Aroon
ODDS (%)
Bullish Trend 3 days ago
49%
Bullish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
HLTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QRSIX44.510.44
+1.00%
FPA Queens Road Small Cap Value Instl
AGCTX21.510.19
+0.89%
American Century Global Small Cap R6
TCIEX27.430.23
+0.85%
Nuveen International Eq Idx R6
FTVNX33.530.27
+0.81%
FullerThaler Behav Md-Cp Val Investor
TORCX18.830.07
+0.37%
Tortoise Energy Infrastructure TR C

HLTRF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLTRF has been loosely correlated with PHCUF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HLTRF jumps, then PHCUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLTRF
1D Price
Change %
HLTRF100%
-0.78%
PHCUF - HLTRF
38%
Loosely correlated
N/A
INCR - HLTRF
21%
Poorly correlated
+1.39%
GTBIF - HLTRF
3%
Poorly correlated
-2.02%
ESALF - HLTRF
3%
Poorly correlated
-2.37%
INDV - HLTRF
2%
Poorly correlated
+4.87%
More